Transcriptome modification of anodal transcranial direct current stimulation in transgenic Parkinson’s disease mouse model
Objective: We tried to investigate the impact of tDCS on mRNA and microRNA expression in striatum and substantia nigra of transgenic mouse model of PD.…The Role of Environmental Toxins (Rotenone) in Parkinson’s Disease
Objective: Learn the role of environmental toxins - rotenone in development of Parkinson's disease Background: Rotenone is a powerful pesticide. It is also a lipophilic…The Influence of Sociodemographic Factors on Post-DBS Impulse Control Symptom Severity in Parkinson’s Disease
Objective: To develop a model to predict changes in impulse control symptom severity (ICSS) following deep brain stimulation (DBS) in patients with Parkinson’s disease (PD).…The social interaction in patients with Parkinson’s disease from the points of activities of daily living and motor function
Objective: To investigate how the social interaction relates to activities of daily living (ADL) and motor function in patients with Parkinson’s disease (PD). Background: In…Functional connectome in Parkinson’s disease mild cognitive impairment
Objective: To unravel functional connectivity (FC) traits in Parkinson’s disease mild cognitive impairment (PD-MCI). Background: PD-MCI is a well-known risk factor for PD associated dementia.…Frequency-dependent abnormalities of intrinsic brain activity in Parkinson´s disease
Objective: The study objective was to assess the changes in amplitude of low frequency fluctuations (ALFF) in patients with Parkinson´s disease (PD) as compared to…Mitochondrial Complex 1, Sigma 1 Receptor and Synaptic Vesicle protein 2A density in early de novo patients with Parkinson’s Disease: pilot PET data
Objective: In this study, we evaluated the density of Mitochondrial complex 1 (MC1), sigma 1 receptor (s1R) and Synaptic Vesicle protein 2A (SV2A) in early…The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study
Objective: We aimed to investigate the role of synaptic vesicle glycoprotein 2A (SV2A) in Parkinson’s disease dementia (PDD) and Dementia with Lewy bodies (DLB) using…Transcranial Photobiomodulation as an adjunct to Levodopa therapy in patients with Parkinson’s Disease; an open label pilot study
Objective: To explore the effects of transcranial Photobiomodulation (tPBM) on symptoms of Parkinson's Disease and establish this therapy's efficacy as an adjunct to Levodopa. Background:…Diagnosing Dementia with Lewy Bodies – Characterizing the prevalence and underlying relationships between core and supportive clinical features
Objective: To characterize the interrelationship between core and supportive features of Dementia with Lewy Bodies, and identify optimal methods for their detection to inform better…
- « Previous Page
- 1
- …
- 191
- 192
- 193
- 194
- 195
- …
- 405
- Next Page »